MedTrace Logo

MRI in Diagnosing Prostate Cancer

NCT01292291 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 714

Last updated 2013-08-07

No results posted yet for this study

Summary

RATIONALE: Diagnostic procedures, such as magnetic resonance imaging (MRI), may help find prostate cancer and learn the extent of disease.

PURPOSE: This clinical trial is studying the safety of MRI and to see how well it works in diagnosing prostate cancer.

Conditions

Interventions

OTHER

biologic sample preservation procedure

OTHER

laboratory biomarker analysis

OTHER

study of socioeconomic and demographic variables

PROCEDURE

diffusion-weighted magnetic resonance imaging

PROCEDURE

dynamic contrast-enhanced magnetic resonance imaging

PROCEDURE

multiparametric magnetic resonance imaging

PROCEDURE

quality-of-life assessment

PROCEDURE

transperineal prostate biopsy

PROCEDURE

transrectal prostate biopsy

PROCEDURE

ultrasound-guided prostate biopsy

Sponsors & Collaborators

  • University College London Hospitals

    lead OTHER

Principal Investigators

  • Mark Emberton, MD, FRCS, MBBS · University College London Hospitals

Study Design

Purpose
DIAGNOSTIC

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2013-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01292291 on ClinicalTrials.gov